2. Questions
What are the barriers when delivering HEOR data?
How to best quantify cost and benefit to stakeholders?
How is HEOR influencing the new audiences?
What to consider when communicating HEOR
findings?
What to do as a publication planning team?
2
3. One Size Does Not Fit All
Heterogeneity of HTA across the globe
Still evolving, particularly in emerging markets
Main differences:
Transparency
Priority Setting
Openness to stakeholder participation
Suggestions:
Scan you environment and be prepared
Hold on to your local talents
Support research on public policy and outcomes
3
4. Time and Cost of Publications
Underestimation of time and cost
Publications as an afterthought for a project
Confusing HEOR as market research
Designing HEOR studies difficult to publish
Suggestions:
Plan ahead
Goal resetting: Generate data for external audience;
publish on time and on strategy
Think BIG: big issues, big knowledge gaps, big picture
4
5. Quantifying Cost & Benefits
IS IT BEST TO QUANTIFY AT ALL?
Are you proving the obvious?
Are you proving the unbelievable?
Next considerations:
Feasible?
Important to whom?
Alignment with product benefit?
Will the data be published well?
5
6. Data Generation Decisions
Feasibility Importance Alignment Publication
Data MUST HAVE To whom? Rank from Think tier
Generation good to poor Think speed
Idea Note Use this Think big
feasibility’s attribute to Use this picture
link with prioritize attribute to
methodology prioritize Use this
attribute to
refine idea
Go / No Go / Defer
6
7. New HEOR Audience: HTA (system)
High stakes getting higher
EBM HTA CER
EBM = Evidence-based medicine
HTA = Health technology assessment (approach)
CER = Comparative effectiveness research
7
8. Treat Each HTA as Unique
Political National
Traditions Income
Health
Local
System
Practice
Structure Reimburse-
ment
Decisions
8
9. HTA Best Practice
Suggestions:
Trans-
parent Maintain highest allowable
involvement
Attitude is KEY
Ideal Trust-building is the GOAL
Predict-
Fair HTA able
Practice Keep eyes open for the
upcoming development in
real-world data collection
Efficient methods
9
10. Agenda Conflicts: HTA & Mfr
Agenda conflicts will ALWAYS exist and mostly remain
unspoken
HTA is accountable for healthcare budgets
Manufacturer seeks to maximize profit & shareholder
value
Communication goals:
Reduce mistrust
Strive for open and honest dialogue
Obtain accurate information for QUALITY decisions
Encourage and request best practice from HTA
10
11. Pub Planning Considerations
Speed and Timing
Credibility
• Peer-review journals
SHORTCUT
• Collaborators & authors
• Research Methodology
Communication
• Micro-level
• Macro-level
11
12. Do’s & Don’ts
Do:
Follow-through and turn posters into papers
Establish clear rules of engagement with academic
partners
Ongoing refinement of communication strategies
Don’t
Aim for the wrong tier
Plan publications after a study
Involve unsuitable internal reviewers
12
13. On Communication
Which is more helpful to decide whether to pay for a
consultant’s airline club membership?
1. The cost is $500 per year; the consultant travels
between 10-20 trips a year based on previous years’
data.
2. The cost is $500 per year, which is equivalent to 2
hours of chargeable work.
Good statistics aid decisions or shape opinions.1
1. Heath D & Heath C. The Gripping Statistic. Fast Company.
September 2009: 59-60. 13
14. Effective Pub Planning Team
To do: Start early
Multi-disciplinary team
Set rules of engagement
Product values front and center
Continuous refinement
Watch competitive landscape
Change with regulatory environment
Advance with the current state of science
Fortune Favors the Prepared and Adaptable!
14
15. Effective Pub Planning Team
To do: Achieve alignment
Align geographically
Know what to leverage
Know when to adapt
Align functionally
Need process to facilitate information flow
Level of communication effectiveness of resource use
Align externally
External collaborators: Opportunity to publish may be the
only motivation
Regulatory requirements study design and publication
deliverables
15
16. Answers
What are the barriers when delivering HEOR data?
Heterogeneity of HTA; Time & cost involved requires careful
planning
How to best quantify cost and benefit to stakeholders?
Make sure quantification is the way to go; then make decision
systematically
How is HEOR influencing the new audiences?
HTA makes fateful decisions with HEOR data; Each HTA do it
their own way; Keep up with the changes
What are considerations when communicating HEOR findings?
Accurate timing; Maximum credibility; Clear communication
What to do as a publication planning team?
Be prepared, adaptable, & connected
16
17. Additional Readings
Special Issue: Health Technology Assessment in
Evidence-Based Health Care Reimbursement Decision
Around the World: Lessons Learned. Value Health.
2009;12(Suppl 2):S1-S49
Kline R, Day P, Redmayne S. Managing scarcity.
Priority setting and rationing in the NHS.
Buckingham: Open University Press, 1996
Raftery J. Review of NICE’s recommendations, 1999-
2005. BMJ. 2005;332:1266-8
17